Literature DB >> 34340611

The association of aortic elasticity properties with novel inflammatory marker CRP /albumin ratio.

Mustafa Karanfil1, Kadriye Gayretli Yayla2.   

Abstract

OBJECTIVE: Hypertension (HT) is the most important preventable cause of cardiovascular disease and mortality. Aortic elasticity parameters are affected in HT, and inflammation plays a central role in the development of HT. C-reactive protein (CRP) to albumin ratio (CAR) is a novel inflammatory marker. We aimed to evaluate the association of aortic elasticity properties with CAR.
METHODS: A total of newly diagnosed untreated 101 hypertensive patients and 98 control participants were included to study. Clinical, demographic parameters, and blood sample parameters were recorded. Aortic strain, aortic stiffness index (ASI), and aortic distensibility (AoD) as aortic elasticity parameters were obtained from transthoracic echocardiography.
RESULTS: CRP, CAR, ASI were significantly higher in hypertensive patients. (6.32 ± 2.48 vs 8.41 ± 3.35, p:<0.001; 0.158 ± 0.065 vs. 0.204 ± 0.083, p: <0.001; 6.73 ± 1.00 vs. 10.93 ± 1.81, p: <0.001, respectively) Aortic strain and AoD levels were significantly lower in hypertensive patients. (6.75 ± 2.17 vs 7.98 ± 2.27; p: <0.001 vs. 3.05 ± 0.97 vs 5.16 ± 1.01; p: <0.001, respectively).
CONCLUSION: CAR a novel inflammatory marker, which can be obtained from blood samples without additional time and cost, can be useful to predict aortic elasticity properties of hypertensive patients in daily clinical practice.

Entities:  

Keywords:  Albumin; C-reactive protein; aortic elasticity parameters; hypertension; inflammation

Mesh:

Substances:

Year:  2021        PMID: 34340611     DOI: 10.1080/10641963.2021.1960368

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  1 in total

1.  High-Risk Obesity Phenotypes: Target for Multimorbidity Prevention at the ROFEMI Study.

Authors:  Juana Carretero-Gómez; Pablo Pérez-Martínez; José Miguel Seguí-Ripoll; Francisco Javier Carrasco-Sánchez; Nagore Lois Martínez; Esther Fernández Pérez; Onán Pérez Hernández; Miguel Ángel García Ordoñez; Candelaria Martín González; Juan Francisco Vigueras-Pérez; Francesc Puchades; María Cristina Blasco Avaria; María Isabel Pérez Soto; Javier Ena; José Carlos Arévalo-Lorido
Journal:  J Clin Med       Date:  2022-08-09       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.